Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Trading Up 2.4%

Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE)’s stock price was up 2.4% during mid-day trading on Thursday . The company traded as high as $0.45 and last traded at $0.43, approximately 28,343 shares traded hands during mid-day trading. A decline of 96% from the average daily volume of 780,142 shares. The stock had previously closed at $0.42.

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) last announced its quarterly earnings data on Thursday, November 7th. The specialty pharmaceutical company reported ($0.05) EPS for the quarter.

Institutional investors have recently made changes to their positions in the stock. Courier Capital LLC raised its position in Ampio Pharmaceuticals by 7.0% in the second quarter. Courier Capital LLC now owns 379,973 shares of the specialty pharmaceutical company’s stock valued at $147,000 after purchasing an additional 25,000 shares during the period. Cypress Capital Management LLC WY raised its position in Ampio Pharmaceuticals by 23.1% in the second quarter. Cypress Capital Management LLC WY now owns 288,225 shares of the specialty pharmaceutical company’s stock valued at $112,000 after purchasing an additional 54,000 shares during the period. LPL Financial LLC purchased a new stake in Ampio Pharmaceuticals in the second quarter valued at $34,000. Morgan Stanley raised its position in Ampio Pharmaceuticals by 532.1% in the second quarter. Morgan Stanley now owns 150,025 shares of the specialty pharmaceutical company’s stock valued at $58,000 after purchasing an additional 126,291 shares during the period. Finally, Jane Street Group LLC purchased a new stake in Ampio Pharmaceuticals in the second quarter valued at $166,000.

About Ampio Pharmaceuticals (NYSEAMERICAN:AMPE)

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee.

See Also: Market Indexes

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.